Effect of adrenergic agents on salivary composition.
D000322:Adrenergic Agonists / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000681:Amylases / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000494:pharmacology; D010306:Parotid Gland / Q000378:metabolism; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D051381:Rats; D012463:Saliva / Q000201:enzymology / Q000378:metabolism*; D013363:Submandibular Gland / Q000378:metabolism; D013726:Terbutaline / Q000494:pharmacology
D000322:Adrenergic Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D011506:Proteins; D010643:Phenoxybenzamine; D010656:Phenylephrine; D000681:Amylases; D007545:Isoproterenol; D013726:Terbutaline; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine